Details for Patent: 4,012,444

Summary for Patent: 4,012,444

Title:	5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
Abstract:	Compounds of the formula: ##STR1## and physiologically acceptable acid addition salts thereof, in which R.sup.1 is A. an arylalkyl group, the alkyl portion of which contains from 1 to 6 carbon atoms and the aryl portion of which may be substituted by one or more alkoxy groups or hydroxy groups; or B. an aryloxyalkyl group, the alkyl portion of which contains from 1 to 6 carbon atoms, and the aryloxy portion of which is substituted with one or more alkoxy or hydroxy groups. These compounds have a blocking action on both .alpha.- and .beta.-adrenergic receptors. Processes for the production of these compounds and pharmaceutical compositions containing them are also provided.
Inventor(s):	Lunts; Lawrence Henry Charles (London, EN), Collin; David Trevor (London, EN)
Assignee:	Allen & Hanburys Limited (London, EN)
Application Number:	05/420,547
Patent Claim Types: see list of patent claims	Compound;

Drugs Protected by US Patent 4,012,444

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 4,012,444

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	34379/69	Jul 8, 1969

International Family Members for US Patent 4,012,444

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	280996
Austria	300763
Belgium	704037
Belgium	752892
Canada	932734